Deal Announcements

Cell BioSciences Collects $15 Million Venture Capital

Wednesday, November 18, 2009 5:37:00 AM PDT | VentureDeal Staff

Santa Clara, California  --  Biotechnology company Cell Biosciences has landed $15 million for its fourth round of institutional venture capital investment.

Cell Biosciences says that it is focused on advancing protein research through the use of nanoproteomics to develop its capillary-based nano fluidic immunoassay platform.

Investors in the round included Domain Associates, Latterell Venture Partners, the Vertical Group, the Wellcome Trust, Novo A/S and other undisclosed investors.  The company did not disclose how the funding proceeds would be used.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1